BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23046321)

  • 1. Drug-eluting balloons: are they the magic bullet?
    Varcoe RL
    J Endovasc Ther; 2012 Oct; 19(5):581-4. PubMed ID: 23046321
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited commentary.
    Forbes TL
    J Vasc Surg; 2009 Sep; 50(3):690. PubMed ID: 19700100
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous revascularization for peripheral arterial disease: paclitaxel saves the day.
    Mahmud E
    JACC Cardiovasc Interv; 2013 Mar; 6(3):290-2. PubMed ID: 23517841
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment paradigms for the superficial femoral artery: are they a-changin?
    Scheinert D
    JACC Cardiovasc Interv; 2012 Mar; 5(3):339-40. PubMed ID: 22440501
    [No Abstract]   [Full Text] [Related]  

  • 5. The THUNDER trial results: clearing the way or ushering the storm?
    Jaff MR
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):109-10. PubMed ID: 25616823
    [No Abstract]   [Full Text] [Related]  

  • 6. In-stent restenosis management: the best is yet to come.
    van den Berg JC
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-coated balloons--the importance of packing and dosing antiproliferative drugs.
    Hehrlein C
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):287-8. PubMed ID: 26198065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis.
    Ju MH; Rodríguez HE
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe.
    Siablis D; Katsanos K; Karnabatidis D
    J Endovasc Ther; 2010 Aug; 17(4):488-91. PubMed ID: 20681764
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
    Barkat M; Torella F; Antoniou GA
    Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Cutaneous Manifestations after Drug-Coated Balloon Angioplasty.
    Chen W; Lee A; Sabat J; DeVito P; Kraemer C; Zhou W
    Ann Vasc Surg; 2020 Nov; 69():451.e1-451.e4. PubMed ID: 32615205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: is the drug-eluting balloon the answer to the epidemic of restenosis?
    Owens CD
    J Endovasc Ther; 2014 Feb; 21(1):22-4. PubMed ID: 24502480
    [No Abstract]   [Full Text] [Related]  

  • 14. David versus Goliath: the first round.
    Micari A; Vadalà G
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1057-9. PubMed ID: 25234680
    [No Abstract]   [Full Text] [Related]  

  • 15. First use of drug-eluting balloon for below-the-elbow artery occlusion in a hemodialysis patient: a 3-year follow-up.
    Ferraresi R; Fattori SM; Cornacchiari M; Palloshi A
    J Vasc Access; 2013; 14(2):202-3. PubMed ID: 23032952
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: comparative effectiveness of paclitaxel-based femoropopliteal interventions.
    Armstrong EJ
    J Endovasc Ther; 2014 Jun; 21(3):369-72. PubMed ID: 24915583
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary: treatment of femoropopliteal in-stent restenosis for patients with diabetes: do we have an answer to the DEBATE?
    Armstrong EJ; Laird JR
    J Endovasc Ther; 2014 Feb; 21(1):9-11. PubMed ID: 24502478
    [No Abstract]   [Full Text] [Related]  

  • 18. Missing the Forest for the Trees?: Drug-Eluting Balloon Treatment for Infrapopliteal Disease.
    Tsai TT
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1623-5. PubMed ID: 26493254
    [No Abstract]   [Full Text] [Related]  

  • 19. Paclitaxel-coated balloon angioplasty for lower extremity revascularization: a new way to fight in-stent restenosis.
    Manzi M; Cester G; Palena LM
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):567-71. PubMed ID: 20671641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: how do we deal with dissection after angioplasty?
    Fanelli F; Cannavale A; Gazzetti M; D'Adamo A
    J Endovasc Ther; 2013 Dec; 20(6):801-4. PubMed ID: 24325696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.